Skip to main content
. 2018 Feb 9;19:28. doi: 10.1186/s12875-018-0711-z

Fig. 3.

Fig. 3

Mean number of days on sick leave from baseline to 3 months and 4 to 6 months for intervention and control group in the PRIM-CARE trial, as well as number of individuals who returned to work from baseline to 3 months, and 4 to 6 months for intervention and control group. Statistically significantly more patients in the intervention group returned via part-time sick leave to work during baseline to 3 months follow-up (62% vs 43%, p = 0.028)